Luis E. Raez, MD, discusses when minimal residual disease testing can be performed as an option for patients with lung cancer.
Arizona patient dies after contracting donor's lung cancer, exposing rare transplant risks and screening challenges.
Dr. Watanabe and his teams from Niigata University have revealed that PET/CT image analysis using artificial intelligence (AI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback